Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
2006 1
2008 1
2009 2
2013 1
2014 2
2015 3
2016 2
2017 7
2018 18
2019 20
2020 13
2021 11
2022 6
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
The treatment landscape of metastatic prostate cancer.
Yamada Y, Beltran H. Yamada Y, et al. Cancer Lett. 2021 Oct 28;519:20-29. doi: 10.1016/j.canlet.2021.06.010. Epub 2021 Jun 18. Cancer Lett. 2021. PMID: 34153403 Free PMC article. Review.
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer.
Bakht MK, Yamada Y, Ku SY, Venkadakrishnan VB, Korsen JA, Kalidindi TM, Mizuno K, Ahn SH, Seo JH, Garcia MM, Khani F, Elemento O, Long HW, Chaglassian A, Pillarsetty N, Lewis JS, Freedman M, Belanger AP, Nguyen QD, Beltran H. Bakht MK, et al. Among authors: yamada y. Nat Cancer. 2023 May;4(5):699-715. doi: 10.1038/s43018-023-00539-6. Epub 2023 Apr 10. Nat Cancer. 2023. PMID: 37038004 Free PMC article.
Epigenetics in prostate cancer: clinical implications.
Conteduca V, Hess J, Yamada Y, Ku SY, Beltran H. Conteduca V, et al. Among authors: yamada y. Transl Androl Urol. 2021 Jul;10(7):3104-3116. doi: 10.21037/tau-20-1339. Transl Androl Urol. 2021. PMID: 34430414 Free PMC article. Review.
Clinical management for malignant afferent loop obstruction.
Sakai A, Shiomi H, Masuda A, Kobayashi T, Yamada Y, Kodama Y. Sakai A, et al. Among authors: yamada y. World J Gastrointest Oncol. 2021 Jul 15;13(7):684-692. doi: 10.4251/wjgo.v13.i7.684. World J Gastrointest Oncol. 2021. PMID: 34322197 Free PMC article. Review.
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.
Tanaka T, Masuda A, Inoue J, Hamada T, Ikegawa T, Toyama H, Sofue K, Shiomi H, Sakai A, Kobayashi T, Tanaka S, Nakano R, Yamada Y, Ashina S, Tsujimae M, Yamakawa K, Abe S, Gonda M, Masuda S, Inomata N, Uemura H, Kohashi S, Nagao K, Kanzawa M, Itoh T, Ueda Y, Fukumoto T, Kodama Y. Tanaka T, et al. Among authors: yamada y. J Gastroenterol. 2023 Mar;58(3):277-291. doi: 10.1007/s00535-022-01939-8. Epub 2023 Jan 27. J Gastroenterol. 2023. PMID: 36705749
L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.
Rii J, Sakamoto S, Mizokami A, Xu M, Fujimoto A, Saito S, Koike H, Tamura T, Arai T, Yamada Y, Goto Y, Sazuka T, Imamura Y, Suzuki K, Kanai Y, Anzai N, Ichikawa T. Rii J, et al. Among authors: yamada y. Cancer Sci. 2024 Mar;115(3):937-953. doi: 10.1111/cas.16062. Epub 2024 Jan 7. Cancer Sci. 2024. PMID: 38186218 Free PMC article.
Advantage of endoscopic papillectomy for ampullary tumors as an alternative treatment for pancreatoduodenectomy.
Abe S, Sakai A, Masuda A, Miki M, Harada Y, Nagao K, Inomata N, Kohashi S, Uemura H, Masuda S, Ashina S, Gonda M, Yamakawa K, Tsujimae M, Yamada Y, Tanaka T, Kobayashi T, Nakano R, Shiomi H, Tsugawa D, Yanagimoto H, Ajiki T, Kanzawa M, Fukumoto T, Itoh T, Kodama Y. Abe S, et al. Among authors: yamada y. Sci Rep. 2022 Sep 7;12(1):15134. doi: 10.1038/s41598-022-19439-3. Sci Rep. 2022. PMID: 36071180 Free PMC article.
94 results